Bill
Bill > S350
NJ S350
NJ S350Prohibits substance use disorder treatment providers from using deceptive marketing practices.
summary
Introduced
01/13/2026
01/13/2026
In Committee
01/13/2026
01/13/2026
Crossed Over
Passed
Dead
Introduced Session
2026-2027 Regular Session
Bill Summary
This bill prohibits the use of deceptive marketing practices by substance use disorder treatment providers. The bill defines a "treatment provider" as a facility licensed in accordance with section 8 of P.L.1975, c.305 (C.26:2B-14) for substance use disorder treatment or services, a substance use disorder treatment facility issued a certificate of approval pursuant to P.L.1970, c.334 (C.26:2G-21 et seq.), or a recovery residence located within the State. The bill requires each treatment provider in the State to provide accurate and complete information, in plain language, on the types and methods of services provided, the location in which services are provided, and the treatment provider's name and brand name when publishing or disseminating any marketing or advertising materials. Under the bill, it will be an unlawful practice for a treatment provider to: (1) make a false or misleading statement about the treatment provider's status as an in-network or out-of-network provider; (2) provide, or direct any other person or entity to provide, false or misleading information about the identity of, or contact information for, any treatment provider; (3) include false or misleading information about the Internet address of any treatment provider's website, or to surreptitiously direct or redirect a person to another website; (4) suggest or imply that a relationship with another treatment provider exists, unless the other treatment provider has provided express, written consent to indicate that relationship; (5) make a false or misleading statement about the substance use disorder treatment services the treatment provider provides; or (6) make a false or misleading statement about the geographic location of the treatment provider or the geographic location in which the treatment provider provides substance use disorder treatment services. Any treatment provider who violates the provisions of the bill will be liable to a civil penalty of not more than $1,000 for each violation. Any person who suffers any injury or damages as a result of the use or employment by a treatment provider of any method, act, or practice declared unlawful under the bill may bring an action or assert a counterclaim therefor in any court of competent jurisdiction. The court will, in addition to any appropriate legal or equitable relief, award threefold the damages sustained by any person in interest and award reasonable attorney's fees, filing fees, and reasonable costs of suit. The Office of Licensing in the Department of Health may investigate alleged violations of this bill. Upon finding a violation, the division may suspend or revoke the treatment provider's license or certification, if applicable, or may impose a civil penalty against the treatment provider. If the department imposes a civil penalty, the civil penalty will be not more than $1,000 for each violation.
AI Summary
This bill prohibits substance use disorder treatment providers, which include licensed treatment facilities and recovery residences (also known as sober living homes), from engaging in deceptive marketing practices. Providers must ensure their advertising is accurate, complete, and in plain language, clearly stating the services offered, where they are provided, and their name. It will be illegal for providers to make false claims about their network status (in-network or out-of-network), misrepresent their identity or contact information, provide incorrect website details or redirect people to other sites without consent, falsely imply a relationship with another provider, or mislead the public about the services or geographic locations of their treatment. Violators face a civil penalty of up to $1,000 per offense, and individuals harmed by these deceptive practices can sue for triple their damages, plus attorney fees and court costs. The Department of Health's Office of Licensing can investigate violations, potentially suspending or revoking licenses or imposing civil penalties.
Committee Categories
Health and Social Services
Sponsors (2)
Last Action
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (on 01/13/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2026/S350 |
| BillText | https://pub.njleg.gov/Bills/2026/S0500/350_I1.HTM |
Loading...